CHRIS BROWN
Profile
First Name
Middle Name
Last Name
Related Companies
Titles
Company Name
Related People
EXECUTIVE OFFICER
NEERAJ AGRAWAL,
CURT ANDERSON,
WILLIAM BRYANT,
JOHN CONNORS,
BARRY CRIST,
SUNIL DHALIWAL,
JENNIFER DUMAS,
PAUL EDELHERTZ,
TODD FEINROTH,
MITCHELL HILL,
ADAM JACOB,
RORY O-DRISCOLL,
BARRY STEINGLASS
EXECUTIVE OFFICER
STEPHEN ARNOLD,
JAMES BLANKEMEYER,
JAMES BLANKMEYER,
TRACY DOBBS,
TERRY DOUGLASS,
TERRY D. DOUGLASS,
MARY LOU DUBOIS,
MARY LOU DUBOIS,
ADAM KUHN,
JOSEPH MATTEO,
DAVID MILLHORN,
MIKE SOMMI,
MIKE J. SOMMI,
THOMAS WELCH
EXECUTIVE OFFICER
TOM ARENA,
JOHN BAKER,
BRADLEY BOSTIC,
BRADLEY A BOSTIC,
BRADLEY A. BOSTIC,
TOM COOPER,
MELVIN HALL,
MELVIN F HALL,
MELVIN F. HALL,
TIM KOPP,
JEFF LAUTENBACH,
ERIC LU,
DR. JOHN MILLS,
JOHN MILLS,
MARK SHARY,
MARK D SHARY,
MARK D. SHARY,
MICHAEL SHEPARD
EXECUTIVE OFFICER
TOM ARENA,
JOHN BAKER,
BRADLEY BOSTIC,
BRADLEY A BOSTIC,
BRADLEY A. BOSTIC,
TOM COOPER,
MELVIN HALL,
MELVIN F HALL,
MELVIN F. HALL,
TIM KOPP,
JEFF LAUTENBACH,
ERIC LU,
DR. JOHN MILLS,
JOHN MILLS,
MARK SHARY,
MARK D SHARY,
MARK D. SHARY,
MICHAEL SHEPARD
EXECUTIVE OFFICER
TOM ARENA,
JOHN BAKER,
BRADLEY BOSTIC,
BRADLEY A BOSTIC,
BRADLEY A. BOSTIC,
TOM COOPER,
MELVIN HALL,
MELVIN F HALL,
MELVIN F. HALL,
TIM KOPP,
JEFF LAUTENBACH,
ERIC LU,
DR. JOHN MILLS,
JOHN MILLS,
MARK SHARY,
MARK D SHARY,
MARK D. SHARY,
MICHAEL SHEPARD
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
OTHER HEALTH CARE
$1 - $1,000,000
Debt
2025-08-28
D
OTHER TECHNOLOGY
DECLINE TO DISCLOSE
Equity
2024-08-30
D
OTHER HEALTH CARE
$1 - $1,000,000
Equity
2024-01-09
D
OTHER HEALTH CARE
$1 - $1,000,000
Equity
2024-01-09
D
OTHER TECHNOLOGY
DECLINE TO DISCLOSE
Equity
2019-03-25
D/A
OTHER TECHNOLOGY
DECLINE TO DISCLOSE
Equity
2017-07-03
D
OTHER TECHNOLOGY
DECLINE TO DISCLOSE
Equity
2015-09-30
D
INVESTING
$1 - $1,000,000
Equity
2014-11-21
D
OTHER TECHNOLOGY
DECLINE TO DISCLOSE
Equity
2014-05-13
D
OTHER TECHNOLOGY
DECLINE TO DISCLOSE
Equity
2013-04-03
D
OTHER TECHNOLOGY
DECLINE TO DISCLOSE
Equity
2012-12-21
D
BIOTECHNOLOGY
DECLINE TO DISCLOSE
Equity
2012-10-31
D
OTHER TECHNOLOGY
DECLINE TO DISCLOSE
Equity
2012-03-15